Research Ethics Board for Clinical Research Studies in Canada
In October 2001, WIRB established its Canadian Panel in response to Health Canada's
new Division 5 regulations. Since its inception, the Canadian Board has reviewed
all clinical research submitted to WIRB by Canadian investigators.
The composition of the Board meets all of the requirements of the Division 5 regulations.
Initial and ongoing reviews are conducted in accordance with Health Canada's Division
5, the Tri Council Policy Statement, ICH GCP E6 and US CFR Title 21 Parts 50 and
56 and CFR Title 45 Part 46.
The Board meets every two weeks in its office located in Vancouver, BC and is fully
supported by staff at WIRB's headquarters in Olympia, Washington. To avoid delays
in processing Canadian research submissions, all submissions for review by the Canadian
Board must be forwarded to the Olympia office.
WIRB's requirements for Research Ethics Board Attestation forms (REBAs) changed
in August 2007. For more information about how WIRB satisfies the attestation requirements,
go to the WIRB News page.
For more information about WIRB's Canadian Board and its review capabilities, please
contact:
Board Liaison, WIRB Canada
Ph (604) 872-5030
Fax (604) 872-5032
or
WIRB's Client Services
1-800-562-4789
clientservices@wirb.com
|